BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 26148140)

  • 21. Validating Self-Reported Unhealthy Alcohol Use With Phosphatidylethanol (PEth) Among Patients With HIV.
    Eyawo O; Deng Y; Dziura J; Justice AC; McGinnis K; Tate JP; Rodriguez-Barradas MC; Hansen NB; Maisto SA; Marconi VC; O'Connor PG; Bryant K; Fiellin DA; Edelman EJ
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2053-2063. PubMed ID: 33460225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harmful alcohol use among acutely ill hospitalized medical patients in Oslo and Moscow: A cross-sectional study.
    Kabashi S; Vindenes V; Bryun EA; Koshkina EA; Nadezhdin AV; Tetenova EJ; Kolgashkin AJ; Petukhov AE; Perekhodov SN; Davydova EN; Gamboa D; Hilberg T; Lerdal A; Nordby G; Zhang C; Bogstrand ST
    Drug Alcohol Depend; 2019 Nov; 204():107588. PubMed ID: 31590131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of phosphatidylethanol results to self-reported alcohol consumption among young injection drug users.
    Jain J; Evans JL; Briceño A; Page K; Hahn JA
    Alcohol Alcohol; 2014; 49(5):520-4. PubMed ID: 24939855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in Alcohol Use Based on Self-Report and a Quantitative Biomarker, Phosphatidylethanol, in People With HIV.
    McGinnis KA; Tate JP; Bryant KJ; Justice AC; O'Connor PG; Rodriguez-Barradas MC; Crystal S; Cutter CJ; Hansen NB; Maisto SA; Marconi VC; Williams EC; Cook RL; Gordon AJ; Gordon KS; Eyawo O; Edelman EJ; Fiellin DA
    AIDS Behav; 2022 Mar; 26(3):786-794. PubMed ID: 34542779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of high phosphatidylethanol (PEth) levels and their concordance with self-reported heavy alcohol consumption among men who have sex with men who binge drink alcohol.
    McLaughlin MF; Jain JP; Ikeda J; Walker JE; Coffin P; Santos GM
    Alcohol Clin Exp Res; 2022 Aug; 46(8):1565-1579. PubMed ID: 35722862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Rates of Biomarker-Confirmed Alcohol Use Among Pregnant Women Living With HIV in South Africa and Uganda.
    Raggio GA; Psaros C; Fatch R; Goodman G; Matthews LT; Magidson JF; Amanyire G; Cross A; Asiimwe S; Hahn JA; Haberer JE
    J Acquir Immune Defic Syndr; 2019 Dec; 82(5):443-451. PubMed ID: 31567551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do Subjective Alcohol Screening Tools Correlate with Biomarkers Among High-Risk Transgender Women and Men Who Have Sex with Men in Lima, Peru?
    Herrera MC; Konda KA; Leon SR; Brown B; Calvo GM; Salvatierra HJ; Caceres CF; Klausner JD; Deiss R
    AIDS Behav; 2017 Nov; 21(Suppl 2):253-261. PubMed ID: 29043467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylethanol and alcohol consumption in reproductive age women.
    Stewart SH; Law TL; Randall PK; Newman R
    Alcohol Clin Exp Res; 2010 Mar; 34(3):488-92. PubMed ID: 20028353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of two counseling interventions on self-reported alcohol consumption, alcohol biomarker phosphatidylethanol (PEth), and viral suppression among persons living with HIV (PWH) with unhealthy alcohol use in Uganda: A randomized controlled trial.
    Hahn JA; Fatch R; Emenyonu NI; Sanyu N; Katusiime A; Levine B; John Boscardin W; Chander G; Hutton H; Camlin CS; Woolf-King SE; Muyindike WR
    Drug Alcohol Depend; 2023 Mar; 244():109783. PubMed ID: 36706675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot investigation of a phosphatidylethanol-based contingency management intervention targeting alcohol use.
    McDonell MG; Skalisky J; Leickly E; Orr MF; McPherson S; Roll J; Hill-Kapturczak N; Javors M
    Psychol Addict Behav; 2017 Aug; 31(5):608-613. PubMed ID: 28714726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Providing context for phosphatidylethanol as a biomarker of alcohol consumption with a pharmacokinetic model.
    Simon TW
    Regul Toxicol Pharmacol; 2018 Apr; 94():163-171. PubMed ID: 29408287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-Response Characteristics of the Alcohol Biomarker Phosphatidylethanol (PEth)-A Study of Outpatients in Treatment for Reduced Drinking.
    Helander A; Hermansson U; Beck O
    Alcohol Alcohol; 2019 Dec; 54(6):567-573. PubMed ID: 31529064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized Study of Assessment Effects on Alcohol Use by Persons With HIV in Rural Uganda.
    Emenyonu NI; Fatch R; Muyindike WR; Kekibiina A; Woolf-King S; Hahn JA
    J Stud Alcohol Drugs; 2017 Mar; 78(2):296-305. PubMed ID: 28317511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphatidylethanol Detects Moderate-to-Heavy Alcohol Use in Liver Transplant Recipients.
    Fleming MF; Smith MJ; Oslakovic E; Lucey MR; Vue JX; Al-Saden P; Levitsky J
    Alcohol Clin Exp Res; 2017 Apr; 41(4):857-862. PubMed ID: 28196282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and change in alcohol consumption in older adults over time, assessed with self-report and Phosphatidylethanol 16:0/18:1 -The HUNT Study.
    Tevik K; Skråstad RB; Benth JŠ; Selbæk G; Bergh S; Eldholm RS; Krokstad S; Helvik AS
    PLoS One; 2024; 19(5):e0304714. PubMed ID: 38820445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study.
    Javors MA; Hill-Kapturczak N; Roache JD; Karns-Wright TE; Dougherty DM
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1228-34. PubMed ID: 27130527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for hazardous alcohol use in the Emergency Department: Comparison of phosphatidylethanol with the Alcohol Use Disorders Identification Test and the Timeline Follow-back.
    Verheij C; Haagsma JA; Koch BCP; Segers AEM; Schuit SCE; Rood PPM
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2225-2235. PubMed ID: 36520053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving screening for alcohol consumption during pregnancy with phosphatidylethanol.
    Bracero LA; Maxwell S; Nyanin A; Seybold DJ; White A; Broce M
    Reprod Toxicol; 2017 Dec; 74():104-107. PubMed ID: 28939493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.
    Stewart SH; Koch DG; Willner IR; Anton RF; Reuben A
    Alcohol Clin Exp Res; 2014 Jun; 38(6):1706-11. PubMed ID: 24848614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of phosphatidylethanol blood concentrations for screening alcohol consumption in early pregnancy.
    Kwak HS; Han JY; Choi JS; Ahn HK; Ryu HM; Chung HJ; Cho DH; Shin CY; Velazquez-Armenta EY; Nava-Ocampo AA
    Clin Toxicol (Phila); 2014 Jan; 52(1):25-31. PubMed ID: 24400931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.